Literature DB >> 17374571

Multi-factor analysis of initial poor graft function after orthotopic liver transplantation.

Hao Chen1, Cheng-Hong Peng, Bai-Yong Shen, Xia-Xing Deng, Chuan Shen, Jun-Jie Xie, Wei Dong, Hong-Wei Li.   

Abstract

BACKGROUND: In the early period of orthotopic liver transplantation (OLT), initial poor graft function (IPGF) is one of the complications which leads to primary graft non-function (PGNF) in serious cases. This study set out to establish the clinical risk factors resulting in IPGF after OLT.
METHODS: Eighty cases of OLT were analyzed. The IPGF group consisted of patients with alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) above 1500 IU/L within 72 hours after OLT, while those in the non-IPGF group had values below 1500 IU/L. Recipient-associated factors before OLT analyzed were age, sex, primary liver disease and Child-Pugh classification; factors analyzed within the peri-operative period were non-heart beating time (NHBT), cold ischemia time (CIT), rewarming ischemic time (RWIT), liver biopsy at the end of cold ischemia; and factors analyzed within 72 hours after OLT were ALT and/or AST values. A logistic regression model was applied to filter the possible factors resulting in IPGF.
RESULTS: Donor NHBT, CIT and RWIT were significantly longer in the IPGF group than in the non-IPGF group; in the logistic regression model, NHBT was the risk factor leading to IPGF (P<0.05), while CIT and RWIT were possible risk factors. In one case in the IPGF group, PGNF appeared with moderate hepatic steatosis.
CONCLUSIONS: Longer NHBT is an important risk factor leading to IPGF, while serious steatosis in the donor liver, CIT and RWIT are potential risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 17374571

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  8 in total

1.  Intraoperative ICG plasma disappearance rate helps to predict absence of early postoperative complications after orthotopic liver transplantation.

Authors:  J J Vos; T W L Scheeren; D J Lukes; M T de Boer; H G D Hendriks; J K G Wietasch
Journal:  J Clin Monit Comput       Date:  2013-05-16       Impact factor: 2.502

2.  The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.

Authors:  Tang Yunhua; Ju Weiqiang; Chen Maogen; Yang Sai; Zhang Zhiheng; Wang Dongping; Guo Zhiyong; He Xiaoshun
Journal:  J Clin Monit Comput       Date:  2017-08-22       Impact factor: 2.502

3.  Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions.

Authors:  Sami Akbulut; Sinasi Sevmis; Hamdi Karakayali; Nilüfer Bayraktar; Muge Unlukaplan; Ergun Oksuz; Atilla Dagdeviren
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Outcomes of liver transplantation using moderately steatotic liver from donation after cardiac death (DCD).

Authors:  Xin Duan; Liting Yan; Yan Shen; Min Zhang; Xueli Bai; Tingbo Liang
Journal:  Ann Transl Med       Date:  2020-09

5.  The PRAISE study: a prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of iloprost in the early postoperative period after liver transplantation (ISRCTN12622749).

Authors:  Erik Bärthel; Falk Rauchfuss; Heike Hoyer; Maria Breternitz; Karin Jandt; Utz Settmacher
Journal:  BMC Surg       Date:  2013-01-29       Impact factor: 2.102

6.  Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.

Authors:  Ismail Ben Mosbah; Yann Mouchel; Julie Pajaud; Catherine Ribault; Catherine Lucas; Alexis Laurent; Karim Boudjema; Fabrice Morel; Anne Corlu; Philippe Compagnon
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.

Authors:  Qinlong Liu; Hasibur Rehman; Yanjun Shi; Yasodha Krishnasamy; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

8.  POST-REPERFUSION LIVER BIOPSY AND ITS VALUE IN PREDICTING MORTALITY AND GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION.

Authors:  Marcos Vinícius Zanchet; Larissa Luvison Gomes da Silva; Jorge Eduardo Fouto Matias; Júlio Cezar Uili Coelho
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.